Edward F. Ellerbeck

Dr. Edward F. Ellerbeck

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 1998 in JAMA
Verified
Journal Article
Open access
PDF file
TMThomas A. Marciniak
Thomas A. Marciniak
EEEdward F. Ellerbeck
Edward F. Ellerbeck
MRMartha J. Radford
Martha J. Radford
TKTimothy F. Kresowik
Timothy F. Kresowik
JGJay A. Gold
Jay A. Gold
SJStephen F. Jencks
Stephen F. Jencks
HEALTH CARE quality is a topic of current concern. Quality has been the focus of recent articles in the medical literature1,2 and is being addressed by a presidential commission. These current concerns about quality are partially motivated by speculations about the effect of managed health care on quality and access, and may be related to a realization that quality cannot be assumed but rather must be understood and engineered.

31 May 2019 in Public Health Nutrition
Verified
Journal Article
Closed access
PDF file
MTMatthew Taylor
Matthew Taylor
DSDebra Kay Sullivan
Debra Kay Sullivan
EEEdward F Ellerbeck
Edward F Ellerbeck
BGByron J Gajewski
Byron J Gajewski
HGHeather Gibbs
Heather Gibbs
Objective: To describe the relationship between adherence to distinct dietary patterns and nutrition literacy.Design: We identified distinct dietary patterns using principal covariates regression (PCovR) and principal components analysis (PCA) from the Diet History Questionnaire II. Nutrition literacy was assessed using the Nutrition Literacy Assessment Instrument (NLit). Cross-sectional relationships between dietary pattern adherence and global and domain-specific NLit scores were tested by multiple linear regression. Mean differences in diet pattern adherence among three predefined nutrition literacy performance categories were tested by ANOVA.Setting: Metropolitan Kansas City, USA.Participants: Adults (n 386) with at least one of four diet-related diseases.Results: Three diet patterns of interest were derived: a PCovR prudent pattern and PCA-derived Western and Mediterranean patterns. After controlling for age, sex, BMI, race, household income, education level and diabetes status, PCovR prudent pattern adherence positively related to global NLit score (P < 0·001, β = 0·36), indicating more intake of prudent diet foods with improved nutrition literacy. Validating the PCovR findings, PCA Western pattern adherence inversely related to global NLit (P = 0·003, β = −0·13) while PCA Mediterranean pattern positively related to global NLit (P = 0·02, β = 0·12). Using predefined cut points, those with poor nutrition literacy consumed more foods associated with the Western diet (fried foods, sugar-sweetened beverages, red meat, processed foods) while those with good nutrition literacy consumed more foods associated with prudent and Mediterranean diets (vegetables, olive oil, nuts).Conclusions: Nutrition literacy predicted adherence to healthy/unhealthy diet patterns. These findings warrant future research to determine if improving nutrition literacy effectively improves eating patterns.

1 November 2006 in Chest
Verified
Journal Article
Closed access
PDF file
TSTheresa I. Shireman
Theresa I. Shireman
JMJonathan D. Mahnken
Jonathan D. Mahnken
PHPatricia A. Howard
Patricia A. Howard
TKTimothy F. Kresowik
Timothy F. Kresowik
QHQingjiang Hou
Qingjiang Hou
EEEdward F. Ellerbeck
Edward F. Ellerbeck

1 October 2004 in Stroke
Verified
Journal Article
Closed access
PDF file
TSTheresa I. Shireman
Theresa I. Shireman
PHPatricia A. Howard
Patricia A. Howard
TKTimothy F. Kresowik
Timothy F. Kresowik
EEEdward F. Ellerbeck
Edward F. Ellerbeck
Background and Purpose— Bleeding risks from combined antiplatelet-warfarin therapy have not been well-described in clinical practice. We examined antiplatelet therapy among warfarin users and the impact on major bleeding rates. Methods— Retrospective cohort analysis of persons discharged on warfarin after an atrial fibrillation admission using data from Medicare’s National Stroke Project. Data included Medicare claims, enrollment information, and medical record abstracted data. Logistic regression and Cox proportional hazards models were used to predict concurrent antiplatelet use and hospitalization with a major acute bleed within 90 days after discharge from the index AF admission. Results— 10 093 warfarin patients met inclusion criteria with a mean age of 77 years; 19.4% received antiplatelet therapy. Antiplatelet use was less common among women, older persons, and persons with cancer, terminal diagnoses, dementia, and bleeding history. Persons with coronary disease were more likely to receive an antiplatelet agent. Antiplatelets increased major bleeding rates from 1.3% to 1.9% ( P =0.052). In the multivariate analysis, factors associated with bleeding events included age (OR, 1.03; 95% CI, 1.002 to 1.05), anemia (OR, 2.52; 95% CI, 1.64 to 3.88), a history of bleeding (OR, 2.40; 95% CI, 1.71 to 3.38), and concurrent antiplatelet therapy (OR, 1.53; 95% CI, 1.05 to 2.22). Conclusions— Although concerns about increased bleeding risk with combined warfarin-antiplatelet therapy are not unfounded, the risk of bleeding is moderately increased. The decision to use concurrent antiplatelet therapy appears to be tempered by cardiac and bleeding risk factors.

1 April 2014 in American Journal of Preventive Medicine
Verified
Journal Article
Closed access
NNNicole L. Nollen
Nicole L. Nollen
MMMatthew S. Mayo
Matthew S. Mayo
SCSusan E. Carlson
Susan E. Carlson
MRMichael A. Rapoff
Michael A. Rapoff
KGKathy J. Goggin
Kathy J. Goggin
EEEdward F. Ellerbeck
Edward F. Ellerbeck

4 June 1997 in JAMA
Verified
Journal Article
Closed access
PDF file
HKHarlan M. Krumholz
Harlan M. Krumholz
JMJaime E. Murillo
Jaime E. Murillo
JCJersey Chen
Jersey Chen
VVViola Vaccarino
Viola Vaccarino
MRMartha J. Radford
Martha J. Radford
YWYun Wang
Yun Wang
Objective. —To determine the correlates of thrombolytic therapy use in a population-based sample of elderly patients hospitalized with acute myocardial infarction who were eligible for the therapy on presentation. Design. —Retrospective cohort study using data from medical charts and administrative files. Setting. —All acute care, nongovernmental hospitals in Connecticut. Patients. —A cohort of 3093 patients aged 65 years and older with a discharge diagnosis of acute myocardial infarction covered by Medicare from May 1992 to May 1993. Results. —Among the 753 patients with ST-segment elevation of 1 mm or more in at least 2 contiguous leads, left bundle branch block not known to be old, and no absolute contraindications to thrombolytic therapy who were not referred for direct angioplasty or bypass surgery, 419 patients (56%) did not receive thrombolytic therapy. The strongest predictors of not receiving thrombolytic therapy included advanced age, absence of chest pain, presentation more than 6 hours after the onset of symptoms, left bundle branch block, total ST-segment elevation of 6 mm or less, presence of Q waves, ST-segment elevation in only 2 leads, and altered mental status. Physicians documented why they did not administer thrombolytic therapy in 19% of the charts. Delay in presentation and increased age were the most common reasons cited. Among the subset of 261 patients who presented with chest pain and within 6 hours of symptoms, 197 (75%) received thrombolytic therapy. Conclusions. —Many eligible and ideal patients for thrombolytic therapy are not treated. Physicians are less likely to use thrombolytic therapy in eligible patients with characteristics associated with an increased risk of bleeding, lower-risk infarction, less certain diagnosis, less certain efficacy, or altered mental status. These findings suggest that the lack of treatment represents a clinical judgment rather than an inadvertent omission. In some cases, such as the lower use of thrombolytic therapy with older age, these judgments are not consistent with the published literature and may represent opportunities to improve care.